Cdc7 as a Potential New Target for Cancer Therapy

被引：18

作者：

Ito, Sayuri ^{[2
]}

Taniyami, Chika ^{[2
]}

Arai, Naoko

Masai, Hisao ^{[1
]}

机构：

[1] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan

[2] SBI Biotech Co Ltd, Dept Res & Dev, Ginko Biomed Res Inst, Kawasaki, Kanagawa, Japan

来源：

DRUG NEWS & PERSPECTIVES | 2008年 / 21卷 / 09期

关键词：

D O I：

10.1358/dnp.2008.21.9.1290818

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cdc7 kinase plays crucial roles in firing of replication origins and in proper maintenance of replication forks, which are the sites of DNA replication. The inactivation of Cdc7 causes destabilization of replication forks leading to acute genomic instability and induces massive cell death preferentially in cancer cells. Thus, Cdc7 kinase may be a promising novel target for cancer therapy. Indeed, the first classes of Cdc7 inhibitors have been reported and have been shown to be effective in delaying tumor growth in animal models.

引用

页码：481 / 488

页数：8

共 73 条

[61]

Takeda T, 1999, MOL CELL BIOL, V19, P5535

[62] Regulation of initiation of S phase, replication checkpoint signaling, and maintenance of mitotic chromosome structures during S phase by Hsk1 kinase in the fission yeast [J].

Takeda, T ;

Ogino, K ;

Tatebayashi, K ;

Ikeda, H ;

Arai, K ;

Masai, H .

MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (05) :1257-1274

[63] Cdc7 is an active kinase in human cancer cells undergoing replication stress [J].

Tenca, Pierluigi ;

Brotherton, Deborah ;

Montagnoli, Alessia ;

Rainoldi, Sonia ;

Albanese, Clara ;

Santocanale, Corrado .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (01) :208-215

[64] Targeting checkpoint kinase 1 in cancer therapeutics [J].

Tse, Archie N. ;

Carvajal, Richard ;

Schwartz, Gary K. .

CLINICAL CANCER RESEARCH, 2007, 13 (07) :1955-1960

[65] Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells [J].

Tsuji, Toshiya ;

Ficarro, Scott B. ;

Jiang, Wei .

MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (10) :4459-4472

[66] MCM proteins in DNA replication [J].

Tye, BK .

ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :649-686

[67] Cdc7 kinase inhibitors: Pyrrolopyridinones as potential antitumor agents. 1. Synthesis and structure-activity relationships [J].

Vanotti, Ermes ;

Amici, Raffaella ;

Bargiotti, Alberto ;

Berthelsen, Jens ;

Bosotti, Roberta ;

Ciavolella, Antonella ;

Cirla, Alessandra ;

Cristiani, Cinzia ;

D'Alessio, Roberto ;

Forte, Barbara ;

Isacchi, Antonella ;

Martina, Katia ;

Menichincheri, Maria ;

Molinari, Antonio ;

Montagnoli, Alessia ;

Orsini, Paolo ;

Pillan, Antonio ;

Roletto, Fulvia ;

Scolaro, Alessandra ;

Tibolla, Marcellino ;

Valsasina, Barbara ;

Varasi, Mario ;

Volpi, Daniele ;

Santocanale, Corrado .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (03) :487-501

[68] Cdc28-Clb5 (CDK-S) and Cdc7-Dbf4 (DDK) collaborate to initiate meiotic recombination in yeast [J].

Wan, Lihong ;

Niu, Hengyao ;

Futcher, Bruce ;

Zhang, Chao ;

Shokat, Kevan M. ;

Boulton, Simon J. ;

Hollingsworth, Nancy M. .

GENES & DEVELOPMENT, 2008, 22 (03) :386-397

[69] Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and the RAD53 checkpoint pathway [J].

Weinreich, M ;

Stillman, B .

EMBO JOURNAL, 1999, 18 (19) :5334-5346

[70] Functional analyses of mouse ASK, an activation subunit for Cdc7 kinase, using conditional ASK knockout ES cells [J].

Yamashita, N ;

Kim, JM ;

Koiwai, O ;

Arai, K ;

Masai, H .

GENES TO CELLS, 2005, 10 (06) :551-563

← 1 2 3 4 5 6 7 8 →